DiaMedica Therapeutics Inc. DMAC

Full chart Compare
Set alert

Price alert · DMAC

All alert types
10.74 USD +0.74 (+7.40%)

Nov 4, 2026, 10:33 AM EST

10.15 Day range 11.00
5.25 52-week range 11.00
YTD
+34.92%
1 year
+60.06%

Revenue & Expenses

Other Income → Expenses: $1.11MExpenses → Selling, General & Admin: $2.74MExpenses → Research & Development: $4.52MExpenses → Income Tax: $80.00KGross Profit → Expenses: $500.00KRevenue → Gross Profit: $500.00KNet Loss → Expenses: $5.73MOther Income$1.11MGross Profit$500.00KNet Loss$5.73MExpenses$7.34MSelling, General & Admin$2.74MResearch & Development$4.52MIncome Tax$80.00KRevenue$500.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

DMAC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
34.40M26.68M21.27M14.00M13.65M
24.61M19.06M13.11M7.84M8.77M
9.78M7.62M8.16M6.16M4.88M
-34.40M-26.68M-21.27M-14.00M-13.65M
28.00K30.00K43.00K28.00K28.00K
-32.77M-24.44M-19.38M-13.70M-13.64M
-32.77M-24.44M-19.38M-13.70M-13.64M
-32.77M-24.44M-19.38M-13.70M-13.64M
-32.77M-24.44M-19.38M-13.68M-13.59M
-0.70-0.60-0.60-0.52-0.65
-0.70-0.60-0.60-0.52-0.65
-0.70-0.60-0.60-0.52-0.65
-32.74M-24.41M-19.34M-13.67M-13.61M
-32.74M-24.41M-19.34M-13.67M-13.61M
46.98M40.40M32.57M26.44M20.77M
46.98M40.40M32.57M26.44M20.77M